Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 409
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00275535 | The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients | ||
| NCT07542678 | Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept | ||
| NCT00394992 | Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer | ||
| NCT00201734 | Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary | ||
| NCT05919342 | Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF" | ||
| NCT01423695 | Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | ||
| NCT02012634 | Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer | ||
| NCT02003703 | Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . | ||
| NCT02499003 | GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma | ||
| NCT06067061 | "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer | ||
| NCT01306409 | Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA) | ||
| NCT00895206 | Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study | ||
| NCT00552201 | TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic | ||
| NCT01935492 | 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer | ||
| NCT00865982 | Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer | ||
| NCT01523340 | A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response | ||
| NCT05017142 | Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) | ||
| NCT00744640 | Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma | ||
| NCT01223547 | Study of the Effects of Carbohydrate Counting | ||
| NCT01953458 | Therapeutic Option for Hepatitis B and C: a French Cohort | ||
| NCT00784446 | First-line Therapy of Stage IV Colorectal Cancer | ||
| NCT03577197 | Southeast Netherlands Advanced Metastatic Breast Cancer Registry | ||
| NCT00411762 | A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma | ||
| NCT05008081 | The CATALINA Study | ||
| NCT05038657 | Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). | ||
| NCT04363853 | Tocilizumab Treatment in Patients With COVID-19 | ||
| NCT00952003 | Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients | ||
| NCT05118724 | Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin | ||
| NCT01471470 | Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer | ||
| NCT05798156 | Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP | ||
| NCT02389283 | Reduced Ultrasound Counts in Rheumatoid Arthritis | ||
| NCT01028092 | mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation | ||
| NCT03275311 | Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | ||
| NCT01059630 | A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN) | ||
| NCT05754502 | Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy | ||
| NCT01697267 | Rituximab Vasculitis Maintenance Study | ||
| NCT03322865 | Obinutuzumab in Marginal Zone Lymphoma | ||
| NCT02120911 | Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma | ||
| NCT00476502 | Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r | ||
| NCT06099418 | Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer. | ||
| NCT00201825 | A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients | ||
| NCT01767597 | Application of HBV Rapid Tests as a Tool for Wide-Use Screening | ||
| NCT01925820 | Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B | ||
| NCT01898117 | Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer | ||
| NCT02739594 | Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma | ||
| NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | ||
| NCT02310503 | Spanish Registry of Mohs Surgery | ||
| NCT00774462 | Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis | ||
| NCT05075538 | COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 | ||
| NCT00275665 | The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection. |
